Medicare Part D Drug Spending Metrics and Trends

Medicare Part D data details spending for drugs prescribed to beneficiaries who self-administer medication. It focuses on average spending per dosage unit and changes over time, including manufacturer spending and drug use information. The dataset is provided by the U.S. Department of Health & Human Services and was last updated in December 2025.

Use Cases

• Analyze trends in average spending per dosage unit over time for specific drugs.
• Compare manufacturer-level spending information across different drug categories.
• Examine the relationship between drug uses, clinical indications, and gross drug cost metrics.
• Track changes in average spending per dosage unit to identify cost drivers in the Part D program.

Strengths

• Data originates from the authoritative U.S. Department of Health & Human Services.
• Includes key financial metrics like average spending per dosage unit and gross drug cost.
• Provides consumer-friendly information on drug uses and clinical indications.

Limitations

• Spending metrics exclude manufacturer rebates and price concessions, potentially overstating net program costs.
• The specific temporal coverage and number of records are not detailed in the provided input.
• Data scope is limited to the U.S. Medicare Part D program.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Based on prescription claim data from the Medicare Part D program.

Freshness

Last updated in December 2025.

Geography

United States